[February 26, 2013] |
|
Hi-Tech Pharmacal to Present at the 2013 RBC Capital Markets' Healthcare Conference
AMITYVILLE, N.Y. --(Business Wire)--
Hi-Tech Pharmacal Co., Inc. (NASDAQ: HITK) today announced that it is
scheduled to make an investor presentation at the 2013 RBC Capital
Markets' Healthcare Conference Wednesday, February 27, 2013, at 11:00
a.m. Eastern Standard Time.
A live audio webcast of the Company's presentation can be accessed on
the Investor Relations page of the Company's website:
http://www.hitechpharm.com
The webcast will be archived within one hour after the live event and
will be available for 90 days.
About Hi-Tech Pharmacal
Hi-Tech Pharmacal is a specialty pharmaceutical company developing,
manufacturing and marketing generic and branded products. The Company
specializes in difficult to manufacture liquid and semi-solid dosage
forms and produces a range of sterile ophthalmic, otic and inhalation
products. The Company's Health Care Products Division is a leading
devloper and marketer of branded prescription and OTC products for the
diabetes marketplace. Hi-Tech's ECR Pharmaceuticals subsidiary markets
branded prescription products.
This press release contains certain future projections and
forward-looking statements (statements which are not historical facts)
with respect to the anticipated future performance of Hi-Tech made
pursuant to the safe harbor provisions of the Private Securities
Litigation Reform Act of 1995. Such future projections and
forward-looking statements are not assurances, promises or guarantees
and investors are cautioned that all future projections and
forward-looking statements involve significant business, economic and
competitive risks and uncertainties, many of which are beyond Hi-Tech's
ability to control or estimate precisely, including, but not limited to,
the impact of competitive products and pricing, product demand and
market acceptance, new product development, the regulatory environment,
including without limitation, reliance on key strategic alliances,
availability of raw materials, fluctuations in operating results, loss
of customers or employees, the possibility that legal proceedings may be
instituted against Hi-Tech and other results and other risks detailed
from time to time in Hi-Tech's filings with the Securities and Exchange
Commission. The actual results will vary from the projected results and
such variations may be material. These statements are based on
management's current expectations and assumptions concerning the future
performance of Hi-Tech and are naturally subject to uncertainty and
changes in circumstances. No representations or warranties are made as
to the accuracy or completeness of any of the information contained
herein, including, but not limited to, any assumptions or projections
contained herein or forward-looking statements based thereon. We caution
you not to place undue reliance upon any such forward-looking statements
which speak only as of the date made, except to the extent specifically
dated as of an earlier date. Hi-Tech is under no obligation, and
expressly disclaims any such obligation, to update, alter or correct any
inaccuracies herein, whether as a result of new information, future
events or otherwise.
[ Back To TMCnet.com's Homepage ]
|